Long QT Syndrome Complicating Atrioventricular Block
Raphaël Rosso(Tel Aviv University), Sami Viskin(Tel Aviv Sourasky Medical Center), Melvin M. Scheinman(University of California, San Francisco), Riyaz Somani(University of Leicester), Manlio F. Márquez(Instituto Nacional de Cardiología), Arie Steinvil(Tel Aviv University), Amos Katz(NeuroRx Research (Canada)), Boris Strasberg(University of California, San Francisco), Mark Kazatsker(University of California, San Francisco), Milton E Guevara-Valdivia(University of California, San Francisco), Adrián Baranchuk(Population Health Research Institute), Arnon Adler(Toronto General Hospital), Bernard Belhassen(Tel Aviv University), Amir Halkin(Tel Aviv University)
Cited by 31
Related Papers
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography
|Atherosclerosis|2012|390
How to use digital devices to detect and manage arrhythmias: an EHRA practical guide
|EP Europace|2022|253
Exercise provocable right ventricular outflow tract tachycardia
|American Heart Journal|1982|120
Predictive value of inter-atrial block for new onset or recurrent atrial fibrillation: A systematic review and meta-analysis
|International Journal of Cardiology|2017|103